Biden-era policies rescinded by Donald Trump could signal a significant shake-up in Medicare and Medicaid drug price reforms.

Metsera, which is developing weight-loss drugs, said on Monday it is seeking a valuation of up to $1.78 billion in its U.S.

Regulators have approved the drug as a treatment for weight loss, Type 2 diabetes and lowering the risk of heart attacks and ...

Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...

The federal Food & Drug Administration (FDA) has bumped up the risk of a salmon recall. This salmon is sold at Costco, and ...

Last Friday, my colleague Julianne McShane and I broke the news of a pair of letters sent by 30 prominent anti-abortion ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

Meanwhile, in an executive order, Trump created his long-discussed “Department of Government Efficiency,” to be led by Elon ...

The Trump administrations removed FDA's plan to ban menthol cigarettes. The Biden administration did not finalize the rule ...

The active ingredient is used in the morning-after pill commonly marketed as “ella” or “ellaOne,” which is advertised as a ...

A Bronx council member wants to force the city’s Department of Health and Mental Hygiene to pick up used drug needles that ...

There were unforgiveable shortcomings in management, which included critical information not reaching senior officials as ...